{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:26:01Z","timestamp":1793474761573,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mycophenolic acid (MPA) is a cornerstone of immunosuppressive treatment in kidney transplant recipients (KTRs). Traditional therapeutic drug monitoring for MPA is based on venous blood sampling. Finger-prick capillary microsampling is patient-friendly and enables limited sampling to predict the area under the curve. A liquid chromatography\u2013tandem mass spectrometry assay to detect MPA and its metabolite mycophenolic acid glucuronide (MPAG) using volumetric absorptive capillary microsampling (VAMS) was developed and clinically validated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An assay based on VAMS and liquid chromatography\u2013tandem mass spectrometry was validated bioanalytically and clinically. Agreement between dried microsamples and plasma samples was investigated in KTR on mycophenolate mofetil therapy. Paired microsamples and plasma samples were obtained before and at 0.5 and 2 hours postdosing. The samples were divided into development (75%) and validation (25%) datasets. Conversion from VAMS to plasma concentrations was established using a regression model, with at least 67% of paired samples required to fall within a mean relative difference of \u00b120%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twelve KTRs (median age: 49 years) provided 69 paired microsamples and plasma samples. For the VAMS method, the between-series mean accuracy was 90%\u2013106% with a coefficient of variation &lt;7% at concentrations of 0.25\u201332 mg\/L (MPA) and 2.5\u2013320 mg\/L (MPAG). A conversion equation based on the regression model was applied and validated using an independent dataset. The mean relative differences between corrected microsamples and plasma samples were 1.9% for MPA and 2.7% for MPAG, with &lt;5% outside \u00b120% for both analytes. Dried microsamples were stable for 3 months at ambient temperature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The VAMS method demonstrated acceptable performance. MPA and MPAG can be reliably quantified using VAMS and are suitable for patient self-sampling in clinical pharmacokinetics studies of KTR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001330","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:01:44Z","timestamp":1744300904000},"page":"790-798","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Development and Clinical Validation of a Volumetric Absorptive Capillary Microsampling Method for Quantification of Mycophenolic Acid and Mycophenolic Acid Glucuronide in Kidney Transplant Recipients"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0413-1548","authenticated-orcid":false,"given":"Ole Martin","family":"Drevland","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Oslo, Oslo, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Skadberg","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Oslo, Oslo, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan Anh","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Oslo, Oslo, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00c5sberg","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Oslo, Oslo, Norway; and"},{"name":"Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Midtvedt","sequence":"additional","affiliation":[{"name":"Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Robertsen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Oslo, Oslo, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"R1-20251107","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200408000-00002","article-title":"Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic acid plasma concentrations","volume":"26","author":"Shaw","year":"2004","journal-title":"Ther Drug Monit"},{"issue":"suppl 1","key":"R2-20251107","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14124","article-title":"OPTN\/SRTR 2015 annual data report: kidney","volume":"17","author":"Hart","year":"2017","journal-title":"Am J Transplant"},{"key":"R3-20251107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00007691-200002000-00003","article-title":"Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation","volume":"22","author":"Shaw","year":"2000","journal-title":"Ther Drug Monit"},{"key":"R4-20251107","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1600-6143.2003.00079.x","article-title":"Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies","volume":"3","author":"Shaw","year":"2003","journal-title":"Am J Transplant"},{"key":"R5-20251107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ftd.0000199358.80013.bd","article-title":"Therapeutic drug monitoring of mycophenolate mofetil in transplantation","volume":"28","author":"van Gelder","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R6-20251107","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther Drug Monit"},{"key":"R7-20251107","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/bcp.14249","article-title":"Effects, costs and implementation of monitoring kidney transplant patients' tacrolimus levels with dried blood spot sampling: a randomized controlled hybrid implementation trial","volume":"86","author":"Veenhof","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"R8-20251107","doi-asserted-by":"crossref","first-page":"e1733","DOI":"10.1097\/TXD.0000000000001733","article-title":"Patiromer does not alter tacrolimus pharmacokinetics in kidney transplant recipients when administered three hours post\u2013tacrolimus","volume":"10","author":"Drevland","year":"2024","journal-title":"Transplant Direct"},{"key":"R9-20251107","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/clinchem\/41.7.1011","article-title":"Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics","volume":"41","author":"Nowak","year":"1995","journal-title":"Clin Chem"},{"key":"R10-20251107","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.clinbiochem.2013.10.011","article-title":"Clinical evaluation of a dried blood spot method for determination of mycophenolic acid in renal transplant patients","volume":"46","author":"Arpini","year":"2013","journal-title":"Clin Biochem"},{"key":"R11-20251107","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00007691-199412000-00012","article-title":"Blood distribution of mycophenolic acid","volume":"16","author":"Langman","year":"1994","journal-title":"Ther Drug Monit"},{"key":"R12-20251107","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther Drug Monit"},{"key":"R13-20251107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FTD.0000000000001024","article-title":"Fingerprick microsampling methods can replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid, and prednisolone concentrations in adult kidney transplant patients","volume":"45","author":"Scuderi","year":"2023","journal-title":"Ther Drug Monit"},{"key":"R14-20251107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"R15-20251107","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"R16-20251107","doi-asserted-by":"crossref","first-page":"e1448","DOI":"10.1097\/TXD.0000000000001448","article-title":"Impact of fasting status and circadian variation on the pharmacokinetics of mycophenolate mofetil and the glucuronide metabolite in renal transplant recipients","volume":"9","author":"Drevland","year":"2023","journal-title":"Transplant Direct"},{"key":"R18-20251107","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/clinchem\/48.9.1497","article-title":"Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus","volume":"48","author":"Pawinski","year":"2002","journal-title":"Clin Chem"},{"key":"R20-20251107","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/bio.14.310","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit","volume":"7","author":"Spooner","year":"2015","journal-title":"Bioanalysis"},{"key":"R21-20251107","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal Chem"},{"key":"R22-20251107","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpba.2018.04.001","article-title":"Extractability-mediated stability bias and hematocrit impact: high extraction recovery is critical to feasibility of volumetric adsorptive microsampling (VAMS) in regulated bioanalysis","volume":"156","author":"Xie","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"R23-20251107","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.07.029","article-title":"Volumetric absorptive microsampling: current advances and applications","volume":"147","author":"Kok","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"R24-20251107","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2017.05.050","article-title":"Application of volumetric absorptive microsampling device for quantification of tacrolimus in human blood as a model drug of high blood cell partition","volume":"143","author":"Kita","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"R25-20251107","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4155\/bio-2018-0312","article-title":"A volumetric absorptive microsampling LC-MS\/MS method for five immunosuppressants and their hematocrit effects","volume":"11","author":"Koster","year":"2019","journal-title":"Bioanalysis"},{"key":"R26-20251107","doi-asserted-by":"crossref","first-page":"113422","DOI":"10.1016\/j.jpba.2020.113422","article-title":"Volumetric Absorptive Microsampling (VAMS) for assaying immunosuppressants from venous whole blood by LC-MS\/MS using a novel atmospheric pressure ionization probe (UniSpray\u2122)","volume":"189","author":"Paniagua-Gonz\u00e1lez","year":"2020","journal-title":"J Pharm Biomed Anal"},{"key":"R27-20251107","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bcp.13911","article-title":"A multiple methods approach to determine adherence with prescribed mycophenolate in children with kidney transplant","volume":"85","author":"Almardini","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"R28-20251107","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/FTD.0000000000000458","article-title":"Development of a liquid chromatography-tandem mass spectrometric method for quantification of mycophenolic acid and its glucuronides in dried blood spot samples","volume":"39","author":"Iboshi","year":"2017","journal-title":"Ther Drug Monit"},{"key":"R29-20251107","doi-asserted-by":"crossref","first-page":"114443","DOI":"10.1016\/j.jpba.2021.114443","article-title":"Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination","volume":"208","author":"Paniagua-Gonz\u00e1lez","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"R30-20251107","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s43440-023-00509-w","article-title":"Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application","volume":"75","author":"Kocur","year":"2023","journal-title":"Pharmacol Rep"},{"key":"R31-20251107","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/FTD.0000000000000422","article-title":"Dried blood spot sampling for tacrolimus and mycophenolic acid in children: analytical and clinical validation","volume":"39","author":"Martial","year":"2017","journal-title":"Ther Drug Monit"},{"key":"R32-20251107","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","volume":"84","author":"Zwart","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"R33-20251107","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1021\/acs.analchem.9b00204","article-title":"An autonomous microfluidic device for generating volume-defined dried plasma spots","volume":"91","author":"Hauser","year":"2019","journal-title":"Anal Chem"},{"key":"R34-20251107","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.trac.2017.10.002","article-title":"Beyond dried blood spot: current microsampling techniques in the context of biomedical applications","volume":"97","author":"Nys","year":"2017","journal-title":"Trends Analyt Chem"},{"key":"R35-20251107","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4155\/bio-2016-0296","article-title":"Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS\/MS systems","volume":"9","author":"Koster","year":"2017","journal-title":"Bioanalysis"},{"key":"R36-20251107","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/j.jchromb.2009.09.037","article-title":"Analysis of mycophenolic acid in dried blood spots using reversed phase high performance liquid chromatography","volume":"877","author":"Wilhelm","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R37-20251107","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/bcp.15433","article-title":"Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients","volume":"88","author":"Zwart","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R38-20251107","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/TP.0000000000001591","article-title":"Clinical validation of simultaneous analysis of tacrolimus, cyclosporine A, and creatinine in dried blood spots in kidney transplant patients","volume":"101","author":"Veenhof","year":"2017","journal-title":"Transplantation"},{"key":"R39-20251107","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","article-title":"Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls","volume":"31","author":"Edelbroek","year":"2009","journal-title":"Ther Drug Monit"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:00:29Z","timestamp":1762542029000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001330","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"2024-11-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}